Danaher (DHR) is a publicly traded Healthcare sector company. As of November 17, 2026, DHR trades at $225.95 with a market cap of $161.75B and a P/E ratio of 42.57. DHR moved -1.80% today. Year to date, DHR is -4.13%; over the trailing twelve months it is +2.35%. Its 52-week range spans $160.93 to $242.80. Analyst consensus is strong buy with an average price target of $258.00. Rallies surfaces DHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DHR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DHR recently traded at $225.95. Market cap is $161.75B. P/E ratio is 42.57. Revenue is $24.78B.
| Metric | Value |
|---|---|
| Price | $225.95 |
| Market Cap | $161.75B |
| P/E Ratio | 42.57 |
| EPS | $5.19 |
| Dividend Yield | 0.40% |
| 52-Week High | $242.80 |
| 52-Week Low | $160.93 |
| Volume | 2.91M |
| Avg Volume | 0 |
| Revenue (TTM) | $24.78B |
| Net Income | $3.69B |
| Gross Margin | 58.94% |
13 analysts cover DHR: 0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $258.00.